Introduction
============

Failed extubation (FE), defined as reintubation within 48 hours of planned extubation (PE), is common. The literature suggests that FE complicates 10 to 20% of PE. The consequences of FE have not been well described, nor have its risk factors.

Methods
=======

We performed a retrospective study of prospectively collected data involving 2,012 consecutive patients undergoing mechanical ventilation (MV) in a 16-bed university-affiliated hospital between 1 October 2005 and 31 August 2011. Eighty-five patients with FE were matched 1:3 with successfully extubated patients (SE) using diagnostic category, age, Acute Physiology Score (APS) and duration of ventilation (DOV) before PE as matching criteria.

Results
=======

Patients undergoing MV included 1,209 (60.1%) with SE; 224 (11.1%) died during ventilation (without prior FE); 206 (10.2%) were extubated to withdraw support; 180 (8.9%) were transferred from the ICU while ventilated; 81 (4.0%) were liberated from MV after tracheostomy; 85 (6.6%) failed PE. APS scores were higher (53 (42 to 69) vs. 43 (32 to 60), *P*\< 0.0001) and DOV before PE longer (1.8 (0.8 to 4.4) vs. 0.9 (0.4 to 2.6), *P*= 0.0001) in FE than in SE. There was 100% concordance of diagnostic category and no statistically significant differences between the groups in regards to age, APS and DOV before PE. Table [1](#T1){ref-type="table"} illustrates the results of the case-control analysis. In addition, FE had more days in the hospital after ICU discharge than did SE: 11 (4 to 24) versus 5 (2 to 9), *P*\< 0.0001.

###### 

Case-control analysis of failed extubation: key outcomes

                  FE                   SE                 *P*value
  --------------- -------------------- ------------------ ----------
  ICU LOS         11.8 (7.7 to 17.5)   3.8 (2.1 to 7.5)   \<0.0001
  VAP (%)         7.1                  0.8                0.0043
  Mortality (%)   23.5                 10.2               0.0052

Conclusion
==========

FE is associated with increased ICU and hospital LOS, increased risk of VAP and increased mortality. Efforts to prospectively identify patients at risk for FE may reduce its incidence and improve outcomes.
